A Phase III Randomized Study of Hypofractionated Image-guided Volumetric Modulated Arc Radiotherapy (IG-VMAT) Versus Conventionally Fractionated IG-VMAT in Patients With Localized Prostate Cancer

Condition: Prostate Cancer

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT02934685

Sponsor: Beijing Hospital

Phase: Phase 3


  • Age: minimum 50 Years maximum 79 Years
  • Gender: Male

Inclusion Criteria:

  • Age 50-79
  • Histologically confirmed prostate adenocarcinoma
  • Clinical stage T1-3N0M0 according to the AJCC 6th edition
  • Gleason score must be >5
  • KPS >70
  • No radical surgery or cryosurgery for prostate cancer

Exclusion Criteria:

  • Prior or concurrent invasive malignancy (except non-melanomatous skin cancer) or lymphomatous/hematogenous malignancy unless continually disease free for a minimum of 5 years. (For example, carcinoma in situ of the bladder or oral cavity is permissible)
  • Evidence of distant metastases
  • Previous radical surgery (prostatectomy) or cryosurgery for prostate cancer
  • Previous pelvic irradiation, prostate brachytherapy, or bilateral orchiectomy
  • Previous or concurrent cytotoxic chemotherapy for prostate cancer

View trial on ClinicalTrials.gov